{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T01:45:18Z","timestamp":1768787118288,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":1653,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jchf.2013.04.010","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T18:30:22Z","timestamp":1375727422000},"page":"361-364","source":"Crossref","is-referenced-by-count":10,"title":["Drug Therapy to Reduce Early\u00a0Readmission\u00a0Risk\u00a0in Heart Failure"],"prefix":"10.1016","volume":"1","author":[{"given":"Muthiah","family":"Vaduganathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai","family":"Gheorghiade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2013.04.010_bib1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jacc.2012.12.038","article-title":"Heart failure-associated hospitalizations in the United States","volume":"61","author":"Blecker","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.04.010_bib2","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1001\/jama.2010.748","article-title":"Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006","volume":"303","author":"Bueno","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2013.04.010_bib3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ahj.2010.02.023","article-title":"Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program","volume":"159","author":"O'Connor","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2013.04.010_bib4","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.04.010_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.297.1.61","article-title":"Association between performance measures and clinical outcomes for patients hospitalized with heart failure","volume":"297","author":"Fonarow","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2013.04.010_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ahj.2009.12.024","article-title":"Relationships between emerging measures of heart failure processes of care and clinical outcomes","volume":"159","author":"Hernandez","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2013.04.010_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"Hunt","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.04.010_bib8","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/jama.2011.1510","article-title":"Hospitalizations for heart failure in the United States\u2013a sign of hope","volume":"306","author":"Gheorghiade","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2013.04.010_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2013.04.010_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2013.02.001","article-title":"Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure","author":"Bourge","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.jchf.2013.04.010_bib11","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.2009.1493","article-title":"Use of aldosterone antagonists in heart failure","volume":"302","author":"Albert","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2013.04.010_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2013.04.010_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2013.04.010_bib14","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1001\/jama.2012.14795","article-title":"Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction","volume":"308","author":"Hernandez","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2013.04.010_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2013.04.010_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/eurjhf\/hft010","article-title":"Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial","volume":"15","author":"Gheorghiade","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2013.04.010_bib17","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2013.04.010_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","article-title":"Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure","volume":"46","author":"Pitt","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.04.010_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/JAHA.111.000018","article-title":"Incremental reduction in risk of death associated with use of guideline-recommended therapies in patients with heart failure: A nested case-control analysis of IMPROVE HF","volume":"1","author":"Fonarow","year":"2012","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jchf.2013.04.010_bib20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2012.03.067","article-title":"Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study","volume":"60","author":"Bradley","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.04.010_bib21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jacc.2012.03.066","article-title":"Hospital strategies to reduce heart failure readmissions: where is the evidence?","volume":"60","author":"Butler","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.04.010_bib22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCHEARTFAILURE.112.967406","article-title":"National survey of hospital strategies to reduce heart failure readmissions: findings from the Get With the Guidelines-Heart Failure registry","volume":"5","author":"Kociol","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2013.04.010_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jama.2012.205110","article-title":"Thirty-day readmissions\u2014the clock is ticking","volume":"309","author":"Vaduganathan","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2013.04.010_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2012.09.038","article-title":"Rehospitalization for heart failure: problems and perspectives","volume":"61","author":"Gheorghiade","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.04.010_bib25","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jacc.2012.12.022","article-title":"Incremental cost-effectiveness of guideline-directed medical therapies for heart failure","volume":"61","author":"Banka","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177913001911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177913001911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T00:50:36Z","timestamp":1539478236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177913001911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S2213177913001911"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2013.04.010","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}